Evidence map›Paper›PMID 21955080›Full record

ArticleNanomedicine (London, England)2011

Emerging technologies in medical applications of minimum volume vitrification.

Xiaohui Zhang, Paolo N Catalano, Umut Atakan Gurkan, Imran Khimji, Utkan Demirci

Abstract read
In one paragraph

Article in Nanomedicine (London, England), 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed.

  1. Review
  2. Review
  3. Review
  4. Review
  5. Review
  6. Article
  7. Review
  8. Review
  9. Article
  10. [Experimental study on high throughput vitrification by micro-droplet spray method].Sheng wu yi xue gong cheng xue za zhi = Journal of biomedical engineering = Shengwu yixue gongchengxue zazhi · 2019
    Article
  11. Article
  12. Article
  13. Article
  14. Bio-inspired solute enables preservation of human oocytes using minimum volume vitrification.Journal of tissue engineering and regenerative medicine · 2018
    Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Xiaohui ZhangBio-Acoustic-MEMS in Medicine (BAMM) Laboratory, Center for Bioengineering, Department of Medicine, Brigham & Women's Hospital, Harvard Medical School, Boston, MA, USA.
Paolo N Catalano
Umut Atakan Gurkan
Imran Khimji
Utkan Demirci

Funding

Microfluidic Chip for Cryopreservation of Blood CellsR21HL095960 · NHLBI · BRIGHAM AND WOMEN'S HOSPITAL · PI DEMIRCI, UTKAN · 2011 to 2012
$491k
Droplet Based Microfluidic Chip for CryopreservationR21EB007707 · NIBIB · BRIGHAM AND WOMEN'S HOSPITAL · PI DEMIRCI, UTKAN · 2008 to 2009
$478k
NHLBI NIH HHS R21 HL095960NIBIB NIH HHS R21 EB007707
6 · The paper itself

Abstract

Cell/tissue biopreservation has broad public health and socio-economic impact affecting millions of lives. Cryopreservation technologies provide an efficient way to preserve cells and tissues targeting the clinic for applications including reproductive medicine and organ transplantation. Among these technologies, vitrification has displayed significant improvement in post-thaw cell viability and function by eliminating harmful effects of ice crystal formation compared to the traditional slow freezing methods. However, high cryoprotectant agent concentrations are required, which induces toxicity and osmotic stress to cells and tissues. It has been shown that vitrification using small sample volumes (i.e., <1 µl) significantly increases cooling rates and hence reduces the required cryoprotectant agent levels. Recently, emerging nano- and micro-scale technologies have shown potential to manipulate picoliter to nanoliter sample sizes. Therefore, the synergistic integration of nanoscale technologies with cryogenics has the potential to improve biopreservation methods.

Indexed as

VitrificationCryopreservationCryoprotective AgentsCryoprotective Agents

Identifiers

PMID21955080
PMCPMC3193162

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.